Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **iron-siderophore complex** is a chemical entity formed when a siderophore, a small high-affinity iron-chelating compound secreted by microorganisms, binds ferric iron (Fe(III)). This complex enables otherwise insoluble iron to be solubilized and transported into bacterial cells through specialized receptor-mediated uptake systems, mainly found in the outer membrane of Gram-negative bacteria[1][2][4][5][6]. The structural diversity of siderophores arises from distinct chelating groups (catecholates, hydroxamates, carboxylates), but all serve the function of scavenging iron from the environment. The iron-siderophore complex is recognized and imported by specific **TonB-dependent transporters** or similar proteins on the bacterial cell surface[4][6]. Inside the cell, iron is reduced and released for metabolic use, and the siderophore may be recycled or degraded[1][2]. Because iron acquisition is essential for bacterial survival and pathogenesis, the corresponding transporters/receptors (not the complex itself) are attractive antimicrobial drug targets, and "Trojan horse" antibiotics use the siderophore pathway for targeted drug delivery[6]. Essential clarification: *Iron-siderophore complex* describes a molecular assembly critical to bacterial iron uptake—highly relevant in microbiology and infection biology but should not be mistaken for a protein, receptor, or classical therapeutic target. Most drugs target the associated transport proteins, not the complex itself.
Drug "hijacking" (drugs conjugated to siderophores are transported into bacteria via iron-siderophore uptake system), Inhibition of iron acquisition pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-siderophore complex.